No BS RX review

No BS RX lists standard semaglutide injection at $149 a month, oral semaglutide at $174 and tirzepatide injection at $225. The three low-dose programs are $115 monthly, with longer-term totals shown separately. Its website names four pharmacy options and offers brand-name pens alongside compounded programs. The remaining disclosure gap is the particular medical group and dispensing pharmacy for your prescription. Its Happy Sleep pages also show a current start path, with separate cash and insurance pricing.

No BS RX provides administrative access to provider-guided weight-loss care rather than practicing medicine or dispensing medication. Its catalog includes compounded semaglutide injection and oral programs, compounded tirzepatide injection, low-dose versions of those three programs, and brand-name Ozempic and Zepbound pens. Happy Sleep delivers the separately offered home sleep-study program and interprets its results.

An independent licensed provider reviews eligibility; the public consent allows asynchronous review and says an in-person assessment may be needed. The current terms name Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx as possible dispensing pharmacies. They do not identify the particular GLP-1 medical group or guarantee which pharmacy fills an order. State availability varies and no complete state list is published. The GLP-1 program price expressly includes the consultation, medication, shipping and ongoing provider messaging; general language about separate third-party fees applies to other programs.

Standard monthly prices are $149 for semaglutide injection, $174 for oral semaglutide and $225 for tirzepatide injection. Their published 12-/24-/52-week totals are $390/$790/$1,551, $497/$987/$1,893 and $548/$1,142/$2,225 respectively. All three low-dose programs cost $115 monthly or $340 for 12 weeks. The cards state the same price at every dose. These term totals should not be treated as calendar-month averages or proof that the entire supply arrives in one shipment; confirm the selected first charge, renewal and delivery schedule.

Brand-name Zepbound pens are $1,299 monthly and Ozempic pens $1,199, separately from compounded programs. A $20 first-order promotion was advertised through October 31; it is a temporary discount, not the recurring program price.

Subscriptions renew for the same duration at the then-current rate, with payment at the beginning of each period. Cancel by emailing support before renewal; cancellation and pauses are handled by support, not a self-service account switch. The current paid period generally is not refunded. There are two initial-refund exceptions: a request within 48 hours of payment before intake or clinical review begins, or a provider declining treatment after the initial review. Dispensed medication cannot be returned. The refund policy gives differing processing and bank-credit ranges, so no fixed arrival date should be assumed.

Happy Sleep lists a $396 cash ring-and-study price, including one visit for the ring and interpretation. The insurance path requires two visits, with copays and coverage depending on the plan. Twelve months of monitoring and app tracking are included; continuing afterward is opt-in. Related therapy is billed separately. The public site has a Get Started path, but individual enrollment, state eligibility and coverage still need confirmation.

Compounded semaglutide is offered by injection and orally; compounded tirzepatide is offered by injection. Standard and low-dose programs have separate prices. Brand-name Ozempic and Zepbound pens are also listed. Compounded preparations are not FDA-approved, and results from trials of the approved products do not establish the safety or effectiveness of a compounded preparation. The site states 503A fulfillment, pharmaceutical-grade ingredients and a Certificate of Analysis requirement. Those are seller sourcing claims, not an independent inspection of an individual prescription. The current catalog does not offer NAD⁺, sermorelin or testosterone.